Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ)
CNY 9.45
(1.07%)
CNY 9.45
(1.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.08 Billion | 413.24 Million | 287.81 Million | 254.89 Million | 239 Million | 203.16 Million |
| Cost of Revenue | 386.22 Million | 249.52 Million | 195.42 Million | 171.79 Million | 148.53 Million | 116.76 Million |
| Gross Profit | 693.82 Million | 163.72 Million | 92.39 Million | 83.1 Million | 90.46 Million | 86.4 Million |
| Operating Expenses | 592.5 Million | 133.83 Million | 97.53 Million | 78.24 Million | 67.15 Million | 71.46 Million |
| Selling, General and Administrative Expenses | 524.63 Million | 100.53 Million | 71.91 Million | 55.53 Million | 48.42 Million | 50.71 Million |
| Research and Development Expenses | 30.17 Million | 9.37 Million | 6.69 Million | 5.97 Million | 7.41 Million | 6.73 Million |
| Other Expenses | -1.03 Million | 5.46 Million | 4.63 Million | 1.57 Million | 500.53 Thousand | -8473.66 |
| Cost and Expenses | 984.85 Million | 383.35 Million | 292.95 Million | 250.04 Million | 215.69 Million | 188.23 Million |
| Operating Income | 95.19 Million | 26.73 Million | -9.38 Million | 2.24 Million | 19.53 Million | 13.52 Million |
| Interest Expense | 4.06 Million | 29.77 Thousand | 534.96 Thousand | 2.06 Million | 733.13 Thousand | 392 Thousand |
| Income Tax Expense | 13.16 Million | 1.9 Million | 1.54 Million | 535.54 Thousand | 4.66 Million | 1.23 Million |
| Earnings before Tax | 97.01 Million | 32.2 Million | -4.74 Million | 3.81 Million | 20.03 Million | 13.51 Million |
| Net Income | 61.64 Million | 25.82 Million | -9.1 Million | 1.83 Million | 12.77 Million | 12.27 Million |
| Earnings Per Share Basic | 0.20 | 0.09 | -0.03 | 0.01 | 0.04 | 0.04 |
| Earnings Per Share Diluted | 0.20 | 0.09 | -0.03 | 0.01 | 0.04 | 0.04 |
| Weighted Average Shares Outstanding | 303.38 Million | 303.34 Million | 303.34 Million | 303.34 Million | 303.34 Million | 303.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 303.38 Million | 303.34 Million | 303.34 Million | 303.34 Million | 303.34 Million | 303.15 Million |
| Gross Margin | 0.64 | 0.40 | 0.32 | 0.33 | 0.38 | 0.43 |
| EBIT Margin | 0.12 | 0.14 | 0.08 | 0.11 | 0.19 | 0.17 |
| Profit Margin | 0.06 | 0.06 | -0.03 | 0.01 | 0.05 | 0.06 |
| EBITDA | 127.72 Million | 93.67 Million | 18.37 Million | 25.44 Million | 40.62 Million | 31.71 Million |
| Earnings Before Tax Margin | 0.09 | 0.06 | -0.03 | 0.01 | 0.08 | 0.07 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 255.38 Million | 291.88 Million | 254.91 Million | 1.08 Billion | 267.74 Million | 220.83 Million |
| Cost of Revenue | 92.65 Million | 73.52 Million | 67.03 Million | 386.22 Million | 118.48 Million | 73.44 Million |
| Gross Profit | 162.72 Million | 218.36 Million | 187.87 Million | 693.82 Million | 149.25 Million | 147.39 Million |
| Operating Expenses | 148.43 Million | 199.65 Million | 151.88 Million | 592.5 Million | 128.94 Million | 127.56 Million |
| Selling, General and Administrative Expenses | 159.1 Million | 193.64 Million | 145.72 Million | - | 87.63 Million | 135.77 Million |
| Research and Development Expenses | 4.94 Million | 6.01 Million | 3.98 Million | - | 9.52 Million | 6.31 Million |
| Other Expenses | -15.61 Million | -2.28 Million | 51.33 Thousand | 1.82 Million | 2.14 Million | -29.82 Thousand |
| Cost and Expenses | 241.09 Million | 273.18 Million | 218.92 Million | 978.73 Million | 247.43 Million | 201 Million |
| Operating Income | 15.16 Million | 18.7 Million | 36.44 Million | 95.19 Million | 20.58 Million | 20.43 Million |
| Interest Expense | 466.71 Thousand | 998.85 Thousand | 909.21 Thousand | 3.94 Million | 1.08 Million | 1.08 Million |
| Income Tax Expense | 4.4 Million | 13.07 Million | 5.69 Million | 13.16 Million | 1.81 Million | 2.95 Million |
| Earnings before Tax | 15.13 Million | 19.08 Million | 36.5 Million | 97.01 Million | 22.73 Million | 20.4 Million |
| Net Income | 3.31 Million | -688.08 Thousand | 22.14 Million | 61.64 Million | 14.81 Million | 14.63 Million |
| Earnings Per Share Basic | 0.01 | -0.00 | 0.07 | - | 0.05 | 0.05 |
| Earnings Per Share Diluted | 0.01 | -0.00 | 0.07 | - | 0.05 | 0.05 |
| Weighted Average Shares Outstanding | 303.34 Million | 303.34 Million | 303.3 Million | 303.38 Million | 303.67 Million | 303.34 Million |
| Weighted Average Shares Outstanding (Diluted) | 303.34 Million | 303.34 Million | 303.3 Million | 303.38 Million | 303.67 Million | 303.34 Million |
| Gross Margin | 0.64 | 0.75 | 0.74 | 0.64 | 0.56 | 0.67 |
| EBIT Margin | 0.06 | 0.09 | 0.15 | - | 0.09 | 0.10 |
| Profit Margin | 0.01 | -0.00 | 0.09 | 0.06 | 0.06 | 0.07 |
| EBITDA | 15.6 Million | 26.76 Million | 37.41 Million | - | 24.09 Million | 21.49 Million |
| Earnings Before Tax Margin | 0.06 | 0.06 | 0.14 | 0.09 | 0.08 | 0.09 |
QTTB
GLOP-PA
SAVE
TRIN
ASAHIINDIA
NAN